Continuous and intermittent infusion of coagulation factor concentrates in patients undergoing surgery: A single centre Australian experience

Australian and New Zealand Journal of Medicine

Volumn 28, Issue 4, 1998, Pages 440-445

  Campbell, P J ^a   Rickard, K A ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Coagulation factor concentrates; Continuous infusion; Haemophilia; Surgery

Indexed keywords

BLOOD CLOTTING FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; FEMALE; HEMOPHILIA; HEMOSTASIS; HUMAN; INTERMETHOD COMPARISON; MALE; ORTHOPEDIC SURGERY; PATIENT CARE; SURGICAL PATIENT; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0031711945     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1998.tb02078.x     Document Type: Article

References (13)

1. Martinowitz U, Schulman S, Gitel S, Horozowski H, Heim M, Varon D. Adjusted dose continuous infusion of factor FVIII in patients with haemophilia A. Br J Haematol 1992; 82: 729-34.
2. Hay CR, Doughty HI, Savidge GF. Continuous infusion of factor VIII for surgery and major bleeding. Blood Coagul Fibrinolysis 1996; 7 (Suppl. 1): S15-19.
3. Hathaway WE, Christian MJ, Clarke SL, Haslba V. Comparison of continuous and intermittent FVIII concentrate therapy in haemophilia A. Am J Hematol 1984; 17: 85-8.
4. Bona RD, Weinstein RA, Weisman SJ, Bartolomeo A, Rickles FR. The use of continuous infusion of factor concentrates in the treatment of haemophilia. Am J Hematol 1989; 32: 8-13.
5. Martinowitz U, Schulman S. Coagulation factor concentrates by continuous infusion. Transfus Med Rev 1997; 11: 56-63.
6. Schulman S, Martinowitz U. Continuous infusion instead of bolus injections of factor concentrate? Haemophilia 1996; 2: 189-91.
7. Hawkins TE, Green GJ, Romeril K, Milicich GS, Carter JS. Treatment of haemophilia A by continuous factor FVIII infusion. Aust NZ J Med 1995; 25: 37-9.
8. Rickard KA. Guidelines for therapy and optimal dosages of coagulation factors for treatment of bleeding and surgery in haemophilia. Haemophilia 1995; 1 (Suppl.): 8-13.
9. Kaspar CK et al. Acquired inhibitors of plasma coagulation factors. J Med Technology 1986; 3: 8.
10. Hutton RA, Ludlam CA. Platelet function testing. J Clin Path 1989; 42: 858-64.
11. McMillan CW, Webster WP, Roberts HR, Blythe WB. Continuous intravenous infusion of factor FVIII in classic haemophilia. Br J Haematol 1970; 18: 659-67.
12. Rock G, Adamkiewicz T, Blanchette V, Poon A, Sparling C. Acquired von Willebrand factor deficiency during high-dose infusion of recombinant factor FVIII. Br J Haematol 1996; 93: 684-7.
13. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep vein thrombosis. Lancet 1995; 345: 152-5.